Story

Cardinal Health Stock Surges on Strong Earnings Beat and New $5B Buyback Plan

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20261 min read
Cardinal Health Stock Surges on Strong Earnings Beat and New $5B Buyback Plan
Text size
Background

Cardinal Health (NYSE: CAH) shares surged on Tuesday after the pharmaceutical distributor reported fiscal fourth-quarter earnings that significantly topped analyst expectations and unveiled a new multi-billion dollar share repurchase plan. The strong results and shareholder-friendly initiatives propelled the stock to a new all-time high in pre-market trading.

Strong Q4 Results Exceed Forecasts

The company announced non-GAAP diluted earnings per share of $2.91 for the quarter, a 40% increase from the same period last year. This figure handily beat the Wall Street consensus estimate of $2.42. According to its earnings release, Cardinal Health's quarterly revenue grew 6% year-over-year to $63.7 billion.

GAAP operating earnings also saw a substantial increase, climbing 70% to $729 million. For the full fiscal year 2026, the company reported non-GAAP EPS of $11.26, a 37% increase year-over-year, alongside a robust operating cash flow of $5.2 billion.

New Buyback and Upbeat Guidance

Sample IUX Markets – In-articleAd

Adding to investor optimism, Cardinal Health's board authorized a new $5.0 billion share repurchase program, which brings the company's total buyback capacity to $6.4 billion. The board also declared a quarterly dividend of $0.5158 per share.

Looking ahead, management issued guidance for fiscal 2027, projecting non-GAAP EPS in the range of $12.40 to $12.60. This forecast implies an expected growth rate of 13% to 15% over fiscal 2026, exceeding market expectations.

Market Reaction

In response to the news, shares of Cardinal Health rose 3.3% in pre-open trading. The move pushed the stock past its prior 52-week high of $244.87, setting a new record. The combination of a significant earnings beat, strong forward guidance, and a large-scale capital return program provided a powerful catalyst, signaling renewed investor confidence in the company's growth and margin expansion trajectory.

Read next

More on Stocks
Back to latest news

LATEST